Jasper Therapeutics, Inc.JSPRWNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+57.8%
5Y CAGR+43.9%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+57.8%/yr
Annual compound
5Y CAGR
+43.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.2x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 5.06 | +381.5% |
| 2023 | 1.05 | +114.5% |
| 2022 | 0.49 | -61.9% |
| 2021 | 1.29 | +362.4% |
| 2020 | -0.49 | -159.8% |
| 2019 | 0.82 | - |